First Time in Man Trial for Friulimicin B

Summary

The purpose of this study is to study the safety of single doses and multiple doses of Friulimicin B in healthy volunteers. The level of Friulimicin B will be measured in the subjects blood and urine. One part of the study will assess if Friulimicin B in the plasma of subjects has activity against bacteria.

Timeline

Start

2007-06

Primary completion

2007-09

Completion

2007-09

Outcome

Outcome not reported

Stopped: “Unfavourable Pharmakokinetics”

Drugs

Indications